{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:59:16Z","timestamp":1785265156025,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,28]]},"DOI":"10.7759\/cureus.113527","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:27:47Z","timestamp":1785263267000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune Thrombocytopenic Purpura: Late-Onset Thrombocytopenia Following Mild COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Hakan","family":"Karatas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Ozdemir Candan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Ocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfur","family":"Toptas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isik","family":"Kaygusuz Atag\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49313","article-title":"Idiopathic thrombocytopenic purpura: current limitations and management","volume":"15","author":"Thakre R","year":"2023","unstructured":"Thakre R, Gharde P, Raghuwanshi M. Idiopathic thrombocytopenic purpura: current limitations and management. Cureus. 2023, 15:e49313. 10.7759\/cureus.49313","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036936","article-title":"Recent advances in the management of immune thrombocytopenic purpura (ITP): a comprehensive review","volume":"103","author":"Madkhali MA","year":"2024","unstructured":"Madkhali MA. Recent advances in the management of immune thrombocytopenic purpura (ITP): a comprehensive review. Medicine. 2024, 103:e36936. 10.1097\/MD.0000000000036936","journal-title":"Medicine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211021161","article-title":"Immune thrombocytopenia and COVID-19: case report and review of literature","volume":"30","author":"Alonso-Beato R","year":"2021","unstructured":"Alonso-Beato R, Morales-Ortega A, Fern\u00e1ndez FJ, Mor\u00f3n AI, R\u00edos-Fern\u00e1ndez R, Rubio JL, Centeno NO. Immune thrombocytopenia and COVID-19: case report and review of literature. Lupus. 2021, 30:1515-21. 10.1177\/09612033211021161","journal-title":"Lupus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-024-03661-0","article-title":"'Wet purpura': a sign of immune thrombocytopenia","volume":"19","author":"Bezerra Machado AI","year":"2024","unstructured":"Bezerra Machado AI, Vieira Fernandes I, Ara\u00fajo M, Pinto L. 'Wet purpura': a sign of immune thrombocytopenia. Intern Emerg Med. 2024, 19:2361-2. 10.1007\/s11739-024-03661-0","journal-title":"Intern Emerg Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S360213","article-title":"Comparison of HIT tests in patients with COVID-19 and thrombocytopenia","volume":"13","author":"Abudouleh E","year":"2022","unstructured":"Abudouleh E, Alhamshari A, Al-Qahtani AA, Aguilos A, Owaidah T. Comparison of HIT tests in patients with COVID-19 and thrombocytopenia. J Blood Med. 2022, 13:357-61. 10.2147\/JBM.S360213","journal-title":"J Blood Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1866545","article-title":"A review on favipiravir: the properties, function, and usefulness to treat COVID-19","volume":"19","author":"Hashemian SM","year":"2021","unstructured":"Hashemian SM, Farhadi T, Velayati AA. A review on favipiravir: the properties, function, and usefulness to treat COVID-19. Expert Rev Anti Infect Ther. 2021, 19:1029-37. 10.1080\/14787210.2021.1866545","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11041088","article-title":"Severe thrombocytopenia as a manifestation of COVID-19 infection","volume":"11","author":"Mocan M","year":"2022","unstructured":"Mocan M, Chiorescu RM, Tirnovan A, Buksa BS, Farca\u0219 AD. Severe thrombocytopenia as a manifestation of COVID-19 infection. J Clin Med. 2022, 11:1088. 10.3390\/jcm11041088","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04318-x","article-title":"Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19","volume":"79","author":"Zhu A","year":"2022","unstructured":"Zhu A, Real F, Capron C, et al.. Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19. Cell Mol Life Sci. 2022, 79:365. 10.1007\/s00018-022-04318-x","journal-title":"Cell Mol Life Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05720-0","article-title":"The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: a nationally representative, prospective, multicentre, observational study","volume":"103","author":"Fu H","year":"2024","unstructured":"Fu H, Cai X, Cui L, et al.. The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: a nationally representative, prospective, multicentre, observational study. Ann Hematol. 2024, 103:1549-59. 10.1007\/s00277-024-05720-0","journal-title":"Ann Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2022.2029699","article-title":"COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis","volume":"15","author":"Alharbi MG","year":"2022","unstructured":"Alharbi MG, Alanazi N, Yousef A, Alanazi N, Alotaibi B, Aljurf M, El Fakih R. COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis. Expert Rev Hematol. 2022, 15:157-66. 10.1080\/17474086.2022.2029699","journal-title":"Expert Rev Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2021.1881225","article-title":"Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases","volume":"26","author":"Taherifard E","year":"2021","unstructured":"Taherifard E, Taherifard E, Movahed H, Mousavi MR. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology. 2021, 26:225-39. 10.1080\/16078454.2021.1881225","journal-title":"Hematology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/519352-immune-thrombocytopenic-purpura-late-onset-thrombocytopenia-following-mild-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:27:48Z","timestamp":1785263268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/519352-immune-thrombocytopenic-purpura-late-onset-thrombocytopenia-following-mild-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.113527","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}